Bays, H., McElhattan, J., Bryzinski, B
Wegovy 7.2 mg is already approved for adults with obesity in the EU and the UK
Ozempic (and its cousins Wegovy, Mounjaro, etc.) work primarily by acting on the brains appetite centers and digestive tract: they make you feel full sooner, slow gastric emptying, and improve insulin sensitivity, which together lead to eating less and storing less fat
These results are largely expected since both SGLT2i and GLP-1RA positively influence renal outcome with different mechanisms, whereas GLP-1RA exert minor effects on hHF,, except in non-diabetic patients with obesity [23]
If you prefer the home option, our Finger-Prick Blood Test Kits page explains the collection method
Guideline NG28